Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 1
2012 4
2013 2
2014 1
2015 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response.
Huang CF, Yang JF, Huang JF, Dai CY, Chiu CF, Hou NJ, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL, Yu ML. Huang CF, et al. J Gastroenterol Hepatol. 2010 Apr;25(4):758-65. doi: 10.1111/j.1440-1746.2009.06148.x. J Gastroenterol Hepatol. 2010. PMID: 20492331
New treatments for HCV: Perspective from Asia.
Yu ML, Chuang WL. Yu ML, et al. Clin Liver Dis (Hoboken). 2015 Mar 4;5(1):17-21. doi: 10.1002/cld.442. eCollection 2015 Jan. Clin Liver Dis (Hoboken). 2015. PMID: 31312438 Free PMC article. Review. No abstract available.
Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial.
Heidrich B, Cordes HJ, Klinker H, Möller B, Naumann U, Rössle M, Kraus MR, Böker KH, Roggel C, Schuchmann M, Stoehr A, Trein A, Hardtke S, Gonnermann A, Koch A, Wedemeyer H, Manns MP, Cornberg M. Heidrich B, et al. PLoS One. 2015 Jun 9;10(6):e0128069. doi: 10.1371/journal.pone.0128069. eCollection 2015. PLoS One. 2015. PMID: 26057627 Free PMC article. Clinical Trial.
Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.
Romero-Gómez M, Turnes J, Ampuero J, Oyagüez I, Cuenca B, Gonzalez-Garcia J, Muñoz-Molina B, Aguilar R, Leal S, Planas R, Garcia-Samaniego J, Diago M, Crespo J, Calleja JL, Casado MA, Sola R. Romero-Gómez M, et al. PLoS One. 2015 Mar 31;10(3):e0122613. doi: 10.1371/journal.pone.0122613. eCollection 2015. PLoS One. 2015. PMID: 25826755 Free PMC article. Clinical Trial.
Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin.
Toyoda H, Kumada T, Shimada N, Takaguchi K, Ide T, Sata M, Ginba H, Matsuyama K, Izumi N. Toyoda H, et al. BMC Infect Dis. 2012 Nov 27;12:324. doi: 10.1186/1471-2334-12-324. BMC Infect Dis. 2012. PMID: 23181537 Free PMC article. Clinical Trial.
Host factors determining the efficacy of hepatitis C treatment.
Chuang WL, Yu ML. Chuang WL, et al. J Gastroenterol. 2013 Jan;48(1):22-30. doi: 10.1007/s00535-012-0669-x. Epub 2012 Oct 27. J Gastroenterol. 2013. PMID: 23104468 Free PMC article. Review.
IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population.
Shi X, Pan Y, Wang M, Wang D, Li W, Jiang T, Zhang P, Chi X, Jiang Y, Gao Y, Zhong J, Sun B, Xu D, Jiang J, Niu J. Shi X, et al. PLoS One. 2012;7(5):e37054. doi: 10.1371/journal.pone.0037054. Epub 2012 May 23. PLoS One. 2012. PMID: 22649509 Free PMC article.
12 results
Jump to page
Feedback